BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

3.875 +0.185 (+5.01%)

Streaming Delayed Price Updated: 3:10 PM EDT, May 12, 2026 Add to My Watchlist

Price and Volume

Volume	16,174
Open	3.760
Bid (Size)	3.800 (1,000)
Ask (Size)	3.920 (100)
Prev. Close	3.690
Today's Range	3.760 - 3.980
52wk Range	3.570 - 12.80
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Today 7:30 EDT

Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows...

Via Newsfile

BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

April 30, 2026

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"...

Via Newsfile

Performance

YTD	-25.6%	-25.6%
1 Month	-9.5%	-9.5%
3 Month	-18.8%	-18.8%
6 Month	-47.0%	-47.0%
1 Year	-41.4%	-41.4%

More News

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

April 29, 2026

Via Newsfile

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

March 31, 2026

Via Newsfile

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

March 31, 2026

Via Newsfile

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

March 26, 2026

Via Newsfile

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

March 17, 2026

Via Newsfile

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

March 05, 2026

Via Newsfile

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

March 03, 2026

Via Newsfile

BioHarvest Sciences Issues Year End Shareholder Letter

January 07, 2026

Via Newsfile

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

December 18, 2025

Via Newsfile

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

December 03, 2025

Via Newsfile

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

November 13, 2025

Via Newsfile

BioHarvest Sciences Inc. - Common Stock Earnings Preview ↗

November 12, 2025

Via Benzinga

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

November 12, 2025

Via Newsfile

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

November 10, 2025

Via Newsfile

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

November 07, 2025

Via Newsfile

BioHarvest Announces Proposed Public Offering of Common Stock

November 06, 2025

Via Newsfile

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

November 04, 2025

Via Newsfile

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

October 30, 2025

Via Newsfile

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

September 22, 2025

Via Newsfile

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

September 10, 2025

Via Newsfile

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

September 02, 2025

Via Newsfile

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

August 11, 2025

Via Newsfile

Frequently Asked Questions

Is BioHarvest Sciences Inc. - Common Stock publicly traded?

Yes, BioHarvest Sciences Inc. - Common Stock is publicly traded.

What exchange does BioHarvest Sciences Inc. - Common Stock trade on?

BioHarvest Sciences Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioHarvest Sciences Inc. - Common Stock?

The ticker symbol for BioHarvest Sciences Inc. - Common Stock is BHST on the Nasdaq Stock Market

What is the current price of BioHarvest Sciences Inc. - Common Stock?

The current price of BioHarvest Sciences Inc. - Common Stock is 3.875

When was BioHarvest Sciences Inc. - Common Stock last traded?

The last trade of BioHarvest Sciences Inc. - Common Stock was at 05/12/26 03:10 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.